Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study.

By L. Locati, P. Bossi, F. Perrone, P. Potepan, F. Crippa, L. Mariani, Paola Casieri, M. Orsenigo, M. Losa, C. Bergamini and 6 more. 2009